On January 20, 2023, Shanghai Fosun Pharmaceutical Co., Ltd. announced that COMIRNATY®Original/Omicron BA.4/BA.5 bivalent COVID-19 vaccine is officially approved as a regular imported. | January 20, 2023
/PRNewswire/ On 23 December 2022, Fosun International was notified by Global Banking and Finance Review, a famous financial magazine in the United Kingdom,.